In The News

Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test

Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test

December 1, 2021

The search continues for possible interventions that delay and/or reverse biological aging, resulting in extended healthspan and lifespan. Interventions delaying aging in animal models are well established; however, most lack validation in humans. For the full study, click here.

Study Shows Rejuvant Decreases Biological Age By Eight Years in Seven Months

December 3, 2021

A randomized retrospective study of 42 individuals published in Aging, shows Rejuvant, a patent-pending, timed-release CaAKG (calcium alpha-ketoglutarate) plus vitamin A for men and vitamin D for women, decreases biological age by an average of eight years after taking the dietary supplement for approximately seven months. For the full press release, click here.

Can We Live to 200?

May 14, 2021

In the last century, the average human life expectancy doubled. Here’s a roadmap to the innovations that could help us do it again — maybe. By Nicholas St. Fleur, Chloe Williams and Charlie Wood The New York Times looks at interventions to address aging. We are the only commercially available product on the market with data showing a positive effect on healthspan and lifespan. The first suggestion in the article references the work we’ve done with Rejuvant.

Healthy Aging from the Inside Out

September 15, 2020

A recent study suggests calcium alpha-ketoglutarate could positively affect aging, with increases in lifespan, a reduction in frailty, and increase in healthspan.  Read full article…

Alpha-Ketoglutarate Extends Healthspan in Aging Mice

September 4, 2020

A research team led by Dr. Brian Kennedy has shown that administration of alpha-ketoglutarate (AKG), a natural metabolite in the citric acid cycle, improves both lifespan and healthspan in middle-aged mice. Read full article…